What Is Vulvar Skincare? A Guide for Brands Entering V-Care

The vulva is the external part of the female genital anatomy: the labia majora, the labia minora, the clitoral hood, the vestibule and the surrounding skin of the mons pubis and the groin. Vulvar skincare addresses that external skin only. Products intended for internal use fall under a different regulatory framework in the European Union and are outside the scope of cosmetics.

Within the cosmetic boundary there is a great deal a formulator can do. Vulvar skin can feel dry, tight, rough or reactive, and its appearance changes across the menstrual cycle, through pregnancy and the postpartum period, during hormonal transitions and with age. A vulvar skincare range works on hydration, lipid support, softness, comfort and the even appearance of the skin — the same vocabulary used in facial skincare, applied to a much more delicate area.

The category is often described commercially as V-Care. That term is useful because it separates the modern, skincare-led approach from the older intimate hygiene shelf, which was built almost entirely around washes and deodorising claims.

Vulvar skin differs from facial and body skin in ways that matter directly to a formulator. The stratum corneum is thinner in several regions of the vulva, the skin is more permeable, it is frequently occluded by clothing, and it is exposed to friction, moisture and, at times, urine. Permeability means that an ingredient which is well tolerated on the forearm may behave differently here.

The surface environment is also different. The vulvar area sits alongside the vaginal microbiome and has its own resident microbial community, and the pH of the external skin is typically less acidic than the vaginal environment but still lower than facial skin. Formulations that ignore this can feel uncomfortable even when they are entirely safe.

In practice, this shapes several decisions at the bench:

Most vulvar skincare formulations are built from well-characterised cosmetic ingredients rather than exotic actives. Humectants such as glycerin, sodium hyaluronate and panthenol support hydration. Emollients and lipids — squalane, plant butters, ceramide-type materials — support suppleness and the skin barrier. Soothing botanicals such as bisabolol, allantoin or centella extracts are common in comfort-oriented products. Prebiotic-style ingredients appear in ranges positioned around microbiome respect.

Just as important is what is left out. Strong fragrance, high concentrations of ethanol, aggressive exfoliating acids, essential-oil-heavy compositions and harsh anionic surfactants are typically avoided or tightly restricted in this category, because the tolerance margin is smaller than on facial skin.

Whatever the ingredient list, each material must comply with Regulation (EC) No 1223/2009 on cosmetic products, including the restrictions and prohibitions set out in its annexes.

This is where most new entrants get into difficulty. A cosmetic product is defined by its purpose: cleaning, perfuming, changing appearance, protecting, keeping in good condition or correcting body odours. Claims that describe treating, curing or preventing disease move a product outside the cosmetic definition, and in the European Union that reclassification carries an entirely different — and far heavier — regulatory burden.

For vulvar skincare this means the language of infection, therapy and medical outcome is off the table. What remains is still commercially powerful: hydration, comfort, softness, suppleness, reduced feeling of tightness, an even and uniform appearance of the skin, freshness, and support for the skin's natural balance.

Claims must also satisfy Regulation (EU) No 655/2013, which sets common criteria for claims used on cosmetic products: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. In practice, every claim on the pack should be traceable to something in the product file.

A credible V-Care product is supported by a testing plan proportionate to its sensitivity. Stability testing confirms the formulation behaves over its shelf life. Packaging compatibility testing confirms the formula and the container do not interact. Challenge testing validates the preservation system. Tolerance assessment, usually conducted under dermatological supervision on volunteers, provides evidence that the product is well tolerated on sensitive skin.

Brands positioning a product specifically for the intimate area often add a gynaecological-supervision tolerance study, since buyers in pharmacy and professional channels look for it. Consumer perception studies are then used to substantiate sensorial and cosmetic-benefit claims.

Animal testing is prohibited for cosmetic products and ingredients in the European Union under Regulation (EC) No 1223/2009; safety substantiation relies on existing data, in vitro methods and human tolerance studies.

Most brands enter the category with two to four references rather than a single hero product, because intimate care is bought as a routine. A typical opening line-up is a gentle cleanser, a hydrating serum or gel, a comfort cream, and often a mist or a wipe format for convenience.

Positioning then determines the emphasis. A brand serving women in midlife will weight the range towards lipid-rich comfort textures; a maternity brand towards minimal, reassuring formulations; a pharmacy own-label towards fragrance-free formats with strong technical documentation; a spa towards sensorial textures and a coherent scent identity.

Development normally runs from an approved brief to a first production in roughly twelve to twenty weeks, with sampling rounds and the testing plan setting the pace.

Hormonal context shapes how vulvar skin looks and feels. During the reproductive years the area is generally well hydrated and resilient, though friction, depilation, tight clothing and sport can create episodes of dryness or sensitivity. In pregnancy and the postpartum period the skin is often more reactive and the priority becomes gentleness, minimal ingredient lists and comfort in the postpartum period.

In perimenopause and menopause the picture changes again. Lower oestrogen levels are associated with thinner, drier external tissue, and many women describe tightness, roughness and a persistent lack of comfort. Cosmetic formulations cannot address the hormonal cause, but they can support hydration, softness and suppleness, which is exactly what a well-built comfort cream or serum is designed to do.

This is why most V-Care ranges are segmented by life stage rather than by ingredient story. The audience recognises its own situation immediately, and the brief for the laboratory becomes far more precise: which texture, which level of lipids, which fragrance decision, which packaging for ease of use.

Three answers make the first conversation productive: who the product is for, what the customer should feel and notice, and which markets the product will be sold in. Everything else — texture, format, actives, packaging — follows from those decisions and can be shaped with the laboratory.

Vulvar skincare rewards brands that treat it as serious skincare rather than a marketing angle. The audience is well informed, often frustrated by products that overpromise, and quick to recognise restraint and honesty in a formulation.

KYSH Labs develops vulvar and intimate skincare for brands, pharmacies, clinics and hospitality groups, from concept through to GMP ISO 22716 production in Italy.